Policy2h ago
AI Biotech Convergence Outpaces Current Regulations
Current regulatory frameworks treat artificial intelligence and biotechnology as separate entities. This gap creates oversight blind spots as AI-driven protein folding and synthetic biology merge. Regulators must integrate these domains to prevent safety lapses. Practitioners face a fragmented compliance environment that slows the deployment of secure, automated laboratory workflows in the life sciences.